Loading live market data…

Iovance Biotherapeutics, Inc.

NASDAQ:IOVA

$4.42 USD

$0.49 (12.47%)

Volume
28.06M
Average Volume
14.27M
Market Capitalization
$1.58B
P/E Ratio
-4.80
Dividend Yield
0.00%
Price Target
$5.00
Year High
$5.63
Year Low
$1.76
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$3.60

IOVA Estimated and Actual Revenue by Quarter

IOVA Estimated and Actual EPS by Quarter

IOVA Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 2 -29.42M -27.35M -28.2M -29.42M -27.35M -28.2M
2027-09-30 2 -25.93M -24.1M -24.85M -25.93M -24.1M -24.85M
2027-06-30 2 -24.58M -22.85M -23.56M -24.58M -22.85M -23.56M
2027-03-31 2 -22.53M -20.95M -21.6M -22.53M -20.95M -21.6M
2026-12-31 2 -22.47M -20.89M -21.54M -22.47M -20.89M -21.54M
2026-09-30 5 -19.49M -18.81M -19.15M -19.49M -18.81M -19.15M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 2 -18.21M -16.57M -17.24M 2.56B 2.75B 2.63B
2027-09-30 2 -26.79M -24.37M -25.36M 2.25B 2.42B 2.32B
2027-06-30 2 -39.43M -35.87M -37.33M 2.13B 2.3B 2.2B
2027-03-31 2 -45.89M -41.74M -43.44M 1.96B 2.11B 2.02B
2026-12-31 2 -49.8M -45.3M -47.15M 1.95B 2.1B 2.01B
2026-09-30 5 -53.77M -47.44M -50.6M 1.76B 1.82B 1.79B
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 2 136.74M 147.1M 141M 1 -0.04351788 -0.03958341 -0.0412
2027-09-30 2 120.52M 129.64M 124.27M 1 -0.0640093 -0.0582222 -0.0606
2027-06-30 2 114.24M 122.9M 117.8M 1 -0.09421832 -0.08570001 -0.0892
2027-03-31 2 104.74M 112.67M 108M 1 -0.10964 -0.09972714 -0.1038
2026-12-31 2 104.46M 112.37M 107.71M 1 -0.11899 -0.10823 -0.11265
2026-09-30 5 94.07M 97.47M 95.77M 5 -0.12847 -0.11335 -0.12091